A Competing Risk Analysis Model to Determine the Prognostic Value of Isolated Tumor Cells in Axillary Lymph Nodes for T1N0M0 Breast Cancer Patients Based on the Surveillance, Epidemiology, and End Results Database

MLA

Yijun Li, et al. “A Competing Risk Analysis Model to Determine the Prognostic Value of Isolated Tumor Cells in Axillary Lymph Nodes for T1N0M0 Breast Cancer Patients Based on the Surveillance, Epidemiology, and End Results Database.” Frontiers in Oncology, vol. 10, Sept. 2020. EBSCOhost, https://doi.org/10.3389/fonc.2020.572316.

APA

Yijun Li, Huimin Zhang, Wei Zhang, Yu Ren, Yan Qiao, Kunlong Li, Heyan Chen, Shengyu Pu, Jianjun He, & Can Zhou. (2020). A Competing Risk Analysis Model to Determine the Prognostic Value of Isolated Tumor Cells in Axillary Lymph Nodes for T1N0M0 Breast Cancer Patients Based on the Surveillance, Epidemiology, and End Results Database. Frontiers in Oncology, 10. https://doi.org/10.3389/fonc.2020.572316

Chicago

Yijun Li, Huimin Zhang, Wei Zhang, Yu Ren, Yan Qiao, Kunlong Li, Heyan Chen, Shengyu Pu, Jianjun He, and Can Zhou. 2020. “A Competing Risk Analysis Model to Determine the Prognostic Value of Isolated Tumor Cells in Axillary Lymph Nodes for T1N0M0 Breast Cancer Patients Based on the Surveillance, Epidemiology, and End Results Database.” Frontiers in Oncology 10 (September). doi:10.3389/fonc.2020.572316.